A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...

Columnist Ann Reynoso, who's now preparing for a bilateral lung transplant, is counting on her strength and perseverance to ...

Nerandomilast worked better than a placebo to preserve lung function in adults with progressive pulmonary fibrosis in a Phase ...

An expert discusses the current understanding of corticosteroids in managing pulmonary fibrosis and how it has evolved in ...

A charity, Action for Pulmonary Fibrosis (APF) say that "rounded and swollen fingertips (clubbed fingers)" could be a sign of a fatal disease. Idiopathic pulmonary fibrosis (IPF) is a condition in ...

An international team of researchers has, for the first time, created a detailed map of the location and identity of individual cells in the adult lung, both from healthy lungs and in lungs from ...

Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.

Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in ...

Idiopathic Pulmonary Fibrosis, the condition that led to the ... In the Indian scenario, patients have been seen to be living for at least 10 to 12 years from the onset of the disease.

Boehringer Ingelheim (BI) has announced positive top-line results from a late-stage study of its investigational ...

Topline data from FIBRONEER™-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change ...

Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...